Yesterday I promised that if we just waited patiently, the remaining questions about Steven Soderbergh’s upcoming movie Side Effects would soon be answered, and a whole new set of questions would probably arise. Oh, how true that was. Before we get into all that, let’s do a brief rundown of the reporting that’s been done on this movie so far.
First it was reported that a “psychopharmacology thriller” that Soderbergh was working on called Bitter Pill was getting its funding through a partnership between Annapurna Pictures and Open Road Films, but that the movie would be called Side Effects going forward. Then came news that Annapurna had pulled their funding, possibly based on concerns they had with Blake Lively being cast in the starring role. It was also theorized that the production was looking at a short list of new actresses to take Lively’s place and save the film some face. Finally, the casting rumors looked to be true, because it was announced that Rooney Mara had been chosen to take Lively’s place as the lead. We were then left only with the question of who would come on board to take Annapurna’s place as this movie’s sugar daddy.
Today that question has been answered, but like promised, we now have a new mystery to solve about this film going forward. THR is reporting that Endgame Entertainment is in negotiations to co-fund the film, with Open Road still handling the distribution duties. That’s the part of the report that makes sense, but there’s more. THR also says that the project will no longer be called Side Effects, but from this point on will be titled Bitter Pill. Say wuh? Isn’t that the title that got changed originally? Is this my Punk’d? Where’s Ashton?